Document is current
Any future updates will be listed below
-
Authors
Lassmann, Michael
Eberlein, Uta
Verburg, Frederik A.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Würzburg
- License Information
-
More Information
Article History
First Online: 2 January 2025
Declarations
:
: Not applicable.
: Not applicable.
: ML has received institutional grants from Novartis and Pentixapharm. UE declares no conflict of interest. FAV is a consultant to GE Healthcare and Immedica and has received speaker honoraria from Bayer and GE Healthcare (all payments made by employer).
